
|Articles|June 1, 2004
Glaucoma drug combination offers effective IOP lowering
Fixed combination compares favorably with concomitant use of prostaglandin analogue, beta-blocker
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
STAAR, Broadwood reach cooperation agreement, restructure board after terminated Alcon deal
2
Ophthalmology pipeline watch: Key trial results and PDUFA dates for Q1 2026
3
PRIMA retinal implant restores vision in patients with advanced GA
4
Ocugen releases positive preliminary 12-month data from phase 2 ArMaDa trial
5














































